A trial of the use of the immunocorrective preparation Imunofan for treating diphtheria

Lebedev, V.V.; Bolibok, V.A.; Borzunov, V.V.; Efimov, N.V.; Tenkachev, V.Z.; Pokrovskiĭ, V.I.

Terapevticheskii Arkhiv 68(2): 66-68

1996


ISSN/ISBN: 0040-3660
PMID: 8771665
Document Number: 466818
Peptide immunocorrector Imunofan was used as adjuvant to conventional treatment. A single intramuscular injection was given daily for 8-10 days (I ml of 0.005% solution). In patients with advanced and toxic diphtheria Imunofan reduced the occurrence of specific complications and lethality fell 4.1-4.8-fold. Imunofan is also recommended for patients with allergic reaction to diphtheria antitoxin.

Document emailed within 1 workday
Secure & encrypted payments